Glassman Wealth Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-349
Closed -$142K 1785
2023
Q4
$142K Buy
349
+4
+1% +$1.48K 0.02% 244
2023
Q3
$120K Buy
345
+2
+0.6% +$699 0.02% 246
2023
Q2
$121K Buy
343
+1
+0.3% +$337 0.02% 242
2023
Q1
$108K Buy
342
+34
+11% +$10.2K 0.02% 254
2022
Q4
$88.9K Buy
308
+11
+4% +$3.35K 0.02% 289
2022
Q3
$86K Buy
297
+17
+6% +$4.89K 0.02% 270
2022
Q2
$79K Buy
280
+47
+20% +$12.6K 0.02% 300
2022
Q1
$61K Sell
233
-95
-29% -$22.5K 0.01% 360
2021
Q4
$72K Buy
328
+218
+198% +$42.4K 0.01% 303
2021
Q3
$20K Buy
110
+10
+10% +$1.95K ﹤0.01% 584
2021
Q2
$20K Sell
100
-8
-7% -$1.67K ﹤0.01% 579
2021
Q1
$23K Buy
108
+18
+20% +$3.95K ﹤0.01% 495
2020
Q4
$21K Sell
90
-82
-48% -$18.8K ﹤0.01% 513
2020
Q3
$47K Buy
172
+48
+39% +$13.2K 0.01% 305
2020
Q2
$36K Buy
124
+33
+36% +$8.95K 0.01% 300
2020
Q1
$22K Sell
91
-17
-16% -$3.9K 0.01% 330
2019
Q4
$24K Buy
108
+3
+3% +$607 0.01% 355
2019
Q3
$18K Buy
105
+18
+21% +$3.18K 0.01% 374
2019
Q2
$16K Sell
87
-9
-9% -$1.57K 0.01% 394
2019
Q1
$18K Buy
96
+66
+220% +$12.2K 0.01% 370
2018
Q4
$5K Hold
30
﹤0.01% 437
2018
Q3
$6K Sell
30
-3
-9% -$534 ﹤0.01% 463
2018
Q2
$6K Buy
33
+5
+18% +$775 ﹤0.01% 427
2018
Q1
$5K Hold
28
﹤0.01% 434
2017
Q4
$4K Buy
28
+3
+12% +$444 ﹤0.01% 441
2017
Q3
$4K Hold
25
﹤0.01% 378
2017
Q2
$3K Hold
25
﹤0.01% 404
2017
Q1
$3K Sell
25
-68
-73% -$5.99K ﹤0.01% 432
2016
Q4
$7K Buy
93
+89
+2,225% +$7.24K 0.01% 409
2016
Q3
$0 Buy
+4
New +$378 ﹤0.01% 590

Other funds holding VRTX